Inspired by these studies on their potential beneficial effects in anti-tumor therapy, we genetically engineered murine mastocytoma line P815 with light-switchable modules (named P815-IFNG) to produce murine IFNG and CXCL10. Here, IFNG is linked to neoplasm.